Tabula Rasa enables medication optimization using its medication risk mitigation technology.
Tabula Rasa Healthcare (formerly CareKinesis) has raised $1.9M in total funding. The most recent round was Grant. The last funding was announced in August 2021.
Tabula Rasa Healthcare (formerly CareKinesis)'s investors include NJEDA, National Institutes of Health, Rittenhouse Ventures, Originate Ventures, Radius Ventures.
Tabula Rasa Healthcare (formerly CareKinesis) is headquartered in Moorestown, United States.
Tabula Rasa enables medication optimization using its medication risk mitigation technology.
Tabula Rasa Healthcare (formerly CareKinesis) is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tabula Rasa Healthcare (formerly CareKinesis) — Funding & Investors." VCBacked, August 25, 2021, https://www.vcbacked.co/company/tabula-rasa-healthcare-formerly-carekinesis. Accessed October 31, 2026.
VCBacked. (2021). Tabula Rasa Healthcare (formerly CareKinesis) — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/tabula-rasa-healthcare-formerly-carekinesis
{{cite web |title=Tabula Rasa Healthcare (formerly CareKinesis) — Funding & Investors |url=https://www.vcbacked.co/company/tabula-rasa-healthcare-formerly-carekinesis |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated